• Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$1.75
+0 (0.00%)

This chart shows the closing price for EMNSF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Elementis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EMNSF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EMNSF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Elementis in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $1.75.

This chart shows the closing price for EMNSF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in Elementis. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/28/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/25/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/23/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/21/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/21/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/5/2023BarclaysLower TargetGBX 139 ➝ GBX 137
7/7/2023JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
7/5/2023BarclaysLower TargetGBX 141 ➝ GBX 139
4/21/2023BarclaysInitiated CoverageEqual Weight ➝ Equal Weight
2/17/2023Jefferies Financial GroupDowngradeBuy ➝ Hold
1/31/2023Jefferies Financial GroupDowngradeBuy ➝ Hold
7/20/2022JPMorgan Chase & Co.Lower TargetGBX 155 ➝ GBX 144
10/13/2021UBS GroupReiterated RatingBuy
7/30/2021JPMorgan Chase & Co.Reiterated RatingNeutral
7/20/2021HSBCUpgradeReduce ➝ Hold$150.00
6/16/2021UBS GroupReiterated RatingBuy
6/4/2021Morgan StanleyReiterated RatingOverweight
5/18/2021Jefferies Financial GroupReiterated RatingBuy
4/30/2021Morgan StanleyReiterated RatingOverweight
4/27/2021JPMorgan Chase & Co.Reiterated RatingNeutral
4/14/2021UBS GroupReiterated RatingBuy
2/25/2021Credit Suisse GroupReiterated RatingOutperform
1/25/2021Morgan StanleyReiterated RatingOverweight
1/20/2021HSBCDowngradeHold ➝ Reduce
11/27/2020Morgan StanleyInitiated CoverageOverweight
10/29/2020Stifel NicolausReiterated RatingHold
8/11/2020Jefferies Financial GroupUpgradeHold ➝ Buy
7/30/2020Stifel NicolausDowngradeBuy ➝ Hold
7/8/2020UBS GroupReiterated RatingBuy
4/30/2020JPMorgan Chase & Co.Reiterated RatingOverweight
4/24/2020Credit Suisse GroupReiterated RatingOutperform
4/7/2020Stifel NicolausUpgradeHold ➝ Buy
3/24/2020JPMorgan Chase & Co.Reiterated RatingOverweight
3/6/2020UBS GroupReiterated RatingBuy
1/8/2020Jefferies Financial GroupDowngradeBuy ➝ Hold
(Data available from 4/21/2019 forward)

News Sentiment Rating

0.59 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/24/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/24/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/23/2023
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/23/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/22/2024
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
2/21/2024
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/22/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/21/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Elementis logo
Elementis plc operates as a specialty chemical company in the United Kingdom, rest of Europe, North America, and internationally. It operates in two segments, Performance Specialties and Personal Care. The Performance Specialties segment engages in the production of rheological modifiers and additives for decorative and industrial coatings; and production and supply of talc for use in plastics, coatings, technical ceramics, and paper sectors. The Personal Care segment provides rheological modifiers and compounded products, including active ingredients for antiperspirants (AP) deodorants for personal care manufacturers. The company offers personal care products for antiperspirants, color cosmetics, and skin care applications; and performance specialties products for architectural coatings, adhesives, sealants and construction additives, and talc applications. Elementis plc was founded in 1844 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $1.75
Low: $1.75
High: $1.75

50 Day Range

MA: $1.71
Low: $1.71
High: $1.75

52 Week Range

Now: $1.75
Low: $1.27
High: $1.85

Volume

N/A

Average Volume

1,322 shs

Market Capitalization

N/A

P/E Ratio

7.17

Dividend Yield

2.03%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Elementis?

The following Wall Street sell-side analysts have issued stock ratings on Elementis in the last year: Barclays PLC, and JPMorgan Chase & Co..
View the latest analyst ratings for EMNSF.

What is the current price target for Elementis?

0 Wall Street analysts have set twelve-month price targets for Elementis in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Elementis in the next year.
View the latest price targets for EMNSF.

What is the current consensus analyst rating for Elementis?

Elementis currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe EMNSF will outperform the market and that investors should add to their positions of Elementis.
View the latest ratings for EMNSF.

What other companies compete with Elementis?

Other companies that are similar to Elementis include AirBoss of America, Akzo Nobel, Alfa, ALPEK and Avantium. Learn More about companies similar to Elementis.

How do I contact Elementis' investor relations team?

Elementis' physical mailing address is Caroline House, London, Greater London. The company's listed phone number is 442070672999. The official website for Elementis is www.elementisplc.com. Learn More about contacing Elementis investor relations.